, ,

RNA Therapeutics

The Evolving Landscape of RNA Therapeutics

Specificaties
Paperback, blz. | Engels
Elsevier Science | e druk, 2022
ISBN13: 9780128215951
Rubricering
Elsevier Science e druk, 2022 9780128215951
€ 195,40
Levertijd ongeveer 8 werkdagen

Samenvatting

RNA Therapeutics: The Evolving Landscape of RNA Therapeutics provides a comprehensive overview of RNA therapeutic modalities, from bench-to-bedside, with an emphasis on the increasingly impactful areas of gene therapy, oligonucleotide therapeutics, gene editing and delivery. International leaders in the field examine RNA-based therapeutics tools that have been developed to-date to modulate cellular processes such as transcription, translation and protein function. Approved RNA-based therapies and lessons learned from failed therapies are discussed in-depth, as are evolving advances in RNA biochemical analysis, and similar advances that are enabling clinical application of RNA-based therapies.

Later sections discuss delivery technologies, remaining hurdles in research and translation, the therapy development process from the lab to the clinic, and novel RNA-based therapies currently in development.

Specificaties

ISBN13:9780128215951
Taal:Engels
Bindwijze:Paperback

Inhoudsopgave

<p>SECTION 1 The world of RNA therapeutics: Available RNA tools to modulate cellular processes<br>1. Targeting chromatin: Transcriptional gene activation (saRNA)<br>2. Argonaute and TNRC6, partners in RNAi<br>3. Targeted RNA therapeutics for treatment of cancer and immunomodulation<br>4. Extrahepatic delivery of RNA to immune cells</p> <p>SECTION 2 Learning from history<br>5. Aptamer-based protein inhibitors<br>6. Lessons learned from developing an oligonucleotide drug for a rare disease</p> <p>SECTION 3 Delivery<br>7. Nucleoside modifications of in vitro transcribed mRNA to reduce immunogenicity and improve translation of prophylactic and therapeutic antigens<br>8. SOMAmer reagents and the SomaScan platform: Chemically modified aptamers and their applications in therapeutics, diagnostics, and proteomics</p> <p>SECTION 4 From bench to bedside<br>9. CMC and regulatory aspects of oligonucleotide therapeutics<br>10. CMC: Regulatory landscape<br>11. CMC and manufacturing</p> <p>SECTION 5 From bench to bedside<br>12. RNA delivery for cancer gene therapy<br>13. Combinatorial RNA therapies in cancer immunotherapy: Challenges and directions</p>
€ 195,40
Levertijd ongeveer 8 werkdagen

Rubrieken

    Personen

      Trefwoorden

        RNA Therapeutics